By LAURAN NEERGAARD and MATTHEW PERRONE
In this file photo dated Wednesday, July 22, 2020, a Pfizer sign is seen on a podium at the Pfizer Research & Development Laboratories, in Groton, USA. The U.K. health authorities rolled out a national mass vaccination program Tuesday Dec. 8, 2020, using the Pfizer-BioNTech COVID-19 vaccine. U.K. regulators said Wednesday Dec. 9, 2020, that people who have a “significant history’’ of allergic reactions shouldn’t receive the new Pfizer/BioNTech vaccine while
A U.S. government advisory panel endorsed widespread use of Pfizer’s coronavirus vaccine Thursday, putting the country just one step away from launching an epic vaccination campaign against the outbreak that has killed close to 300,000 Americans.
Local, state health officials preparing for COVID-19 vaccine
12/9/20 11:22 PM
If all goes as planned, the county hospital will receive its first COVID-19 vaccines next week.
State health officials are confident the Pfizer BioNTech vaccine will be approved, distributed to hospitals and ready to administer by then, they said Wednesday during the state’s weekly news conference.
A Food and Drug Administration subcommittee is expected to make a decision on the Pfizer vaccine today. The FDA released a 52-page report about the vaccine that shows study results are more positive than previously reported by the vaccine maker. The vaccine, the report says, causes only mild side effects and a 95% efficacy rate, meaning only 5% of those who got a dose of the vaccine during the trial later got the virus.